Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

2-sulfamoylacetylphenol

 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

PhenolsSulfonamides

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
1996
Highly Cited
1996
Involvement of mammalian liver cytosols and aldehyde oxidase in reductive metabolism of zonisamide.
Zonisamide (1,2-benzisoxazole-3-methanesulfonamide), an anticonvulsant agent, is primarily metabolized to 2-sulfamoylacetylphenol… Expand
Highly Cited
1993
Highly Cited
1993
Characterization of human liver microsomal cytochrome P450 involved in the reductive metabolism of zonisamide.
Zonisamide (1,2-benzisoxazole-3-methanesulfonamide) was metabolized to 2-sulfamoylacetylphenol (SMAP) in human liver microsomes… Expand
1993
1993
Rat liver microsomal cytochrome P-450 responsible for reductive metabolism of zonisamide.
The reductive metabolism of 1,2-benzisoxazole-3-methanesulfonamide (zonisamide) to 2-sulfamoylacetylphenol (SMAP) was observed in… Expand
1992
1992
Formation of reductive metabolite, 2-sulfamoylacetylphenol, from zonisamide in rat liver microsomes.
Zonisamide (1,2-benzisoxazole-3-methanesulfonamide) was metabolized to its reductive product, 2-sulfamoylacetylphenol, in rat… Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE